RARA CRAFT DATABASE for FDA Medical Devices
510(k)K203278

FDA DEVICE FACTS

INDEPENDENCE Spacers, HEDRON IA, MAGNIFY-S Spacers, MONUMENT Spacers, InterContinental Plate-Spacer, ELSA Spacers

Globus Medical, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEFebruary 2, 2021PRODUCT CODEMAX

Indications for use

Indications for Use: INDEPENDENCE® Spacers INDEPENDENCE® Spacers (including INDEPENDENCE MIS ® and INDEPENDENCE M IS AGX ™) are integrated anterior lumbar interbody fus ion devices indicated for use at one or more levels of the lumbosacral spine (L1-S1), as an adjunct to fusion in patients with the following indications: degenerative disc disease (DDD), disc herniation (with my elopathy and/or radiculopathy), spondylolisthesis, deformity (degenerative scoliosis or kyphosis), spinal stenosis, and failed previous fusion (pseudarthrosi s). DDD is defined as discogenic back pain with degeneration of the disc confirmed by hist ory and radiographic studies. These patients should be skeletally mature and have had at least six (6) months of non- operative treatm ent. All INDEPENDENCE ® TPS coated spacers are indicated for the same use as non-coated PEEK versions. INDEPENDENCE® Spacers are intended to be used with or without three screws which ac company the implants. INDEPENDENCE MIS ® and INDEPENDENCE MIS AGX™ Integrated Spacers are int ended to be used with or without three screws and/or anchors which acc ompany the implants. These devices are intended for use with supplemental fixation (e.g. facet screws or posterior fixation). In addition, these devices are intended for stand-alone use in patients with DDD at one or two levels only when <25° lord otic implants are used with three scr ews per implant. INDEPENDENCE MIS AGX™ S pacers are C-shaped, non-integr ated PEEK spacers that are intended to be used with supplemental fixation (e.g. facet screws or posterior fixation). When used in conjunction with the INDEPENDENCE MIS AGX™ Integrated Ti Spacer, these dev ices become the INDEPENDENCE MIS AGX™ Integrated Spacer.

All INDEPENDENCE® Spacers are to be filled with autograft bone and/or allogenic bone graft composed of cancellous and/or corticocancellous bone. HEDRON IA™ HEDRON IA™ Integrated Lumbar Spacers are integrated lumbar interbody fusion devices indicated for use at one or more levels of the lumbosacral spine (L1-S1), as an adjunct to fusion in patients with the following indications: degenerative disc disease (DDD), disc herniation (with myelopathy and/or radiculopathy), spondylolisthesis, deformity (degenerative scoliosis or kyphosis), spinal stenosis, and failed previous fusion (pseudarthrosis). DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be s keletally mature and have had at least six (6) months of non-operative treatment. These devices are intended to be used with or without three screws and/or anchors whic h accompany the implants. These devices are intended for use with supplemental fixation (e.g. facet screws or posterior fixation). In addition, these devices are intended for stand-alone use in patients with DDD at one or two levels only when <25° lord otic implants are used with thr ee screws per implant. HEDRON IA™ Spac ers are to be fi lled with autograft bone and/or allogenic bone graft composed of cancellous and/or corticocancellous bone. MAGNIFY®-S Spacers The MAGNIFY®-S Spacer is an interbody fusion device indicated for use at one or more levels of the lumbosacral spine (L1- S1), as an adjunct to fusion in patients with the following indications: degener ative disc disease (DDD) , disc herniation (with myelopathy and/or radiculopathy), spondylolisthesis, deformity (degenerative scoliosis or kyphosis), spinal stenosis, and failed previous fusion (pseudarthrosis). DDD is defined as discogenic back pain with degeneration of the dis c confirmed by history and r adiographic studies. These patients should be skeletally mature and have had at least six (6) months of non-operative treatment. The M AGNIFY®-S Spacer is to be used with or without three screws which accompany the implant. These devices are intended for use with supplemental fixation (e.g. facet screws or posterior fixation). In addition, these devices are intended for stand-alone use in patients with DDD at one or two levels only when used with three screws per implant. The MAGNIFY®-S Spacer is to be filled with autograft bone and/or allogeni c bone graft compos ed of cancellous and/or corticocancellous bone. MONUMENT® Spacers The MONUMENT® Spacer is an interbody fusion device indicated for use at one or more levels of the lumbosacral spine (L1-S1), as an adjunct to fusion in patients with the following indications: degener ative disc disease (DDD) , disc herniation (with m yelopathy and/or r adiculopathy), defor mity (degenerative scoliosis or kyphosis), spinal stenosis, and failed previous fusion (pseudarthrosis). In addition, these patients may have up to Gr ade 1 spondylolisthesis or retrolisthesis at the

involved level(s). DDD is defined as discogenic back pain with degeneration of the disc confirmed by histor y and radiographic studies . These patients should be skeletally mature and have had at least six (6) months of non-operative treatment. The MON UMENT® Spacer is to be used with four screws that accompany the implant. These devices are intended for use with supplemental fixation (e.g. facet screws or posterior fixation). The MONUMENT® Spacer is to be filled with autograft bone and/or allogenic bone graft composed of cancellous and/or corticocancellous bone. InterContinental® Plate-Spacer InterContinental® Plate-Spacers are later al lum bar interbody fusion devices indicated for use at one or more levels of the lumbosacral spine (L1- S1), as an adjunct to fusion in patients with the following indications: degenerative dis c disease (DDD), disc herniation (with my elopathy and/or radiculopathy), spondylolisthesis, deformity (degenerative scoliosis or kyphosis), spinal stenosis, and failed previous fusion (ps eudarthrosis). DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and r adiographic studies. These patients should be skeletally mature and have had at least six (6) months of non-operative treatment. All InterContinental® TPS coated spacers are indicated for the same use as non-coated PEEK versions. InterContinental® Plate-Spacers are intended to be used with or without two screws and/or anchors which acc ompany the implants. These devices are intended for use with supplemental fixation (e.g. facet screws or posterior fixation). InterContinental® Plate-Spacers are to be filled with autograft bone and/or allogenic bone graft composed of cancellous and/or corticocancellous bone.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026